Effects of prostaglandin E1 and 15-methyl- prostaglandin E1 on the cardiovascular responses to bilateral carotid arterial occlusion.
D000804:Angiotensin II / Q000494:pharmacology; D000818:Animals; D001157:Arterial Occlusive Diseases / Q000503:physiopathology*; D001794:Blood Pressure / Q000187:drug effects*; D002339:Carotid Arteries / Q000503:physiopathology; D002340:Carotid Artery Diseases / Q000503:physiopathology*; D002404:Catheterization; D003864:Depression, Chemical; D004285:Dogs; D006339:Heart Rate / Q000187:drug effects; D006352:Heart Ventricles / Q000187:drug effects; D006439:Hemodynamics / Q000187:drug effects*; D007263:Infusions, Parenteral; D008026:Ligation; D008239:Lysine / Q000494:pharmacology; D005996:Nitroglycerin / Q000494:pharmacology; D011453:Prostaglandins / Q000008:administration & dosage; D011458:Prostaglandins E / Q000494:pharmacology*; D013268:Stimulation, Chemical; D014159:Transducers; D014628:Vagotomy; D014667:Vasopressins / Q000494:pharmacology
D011453:Prostaglandins; D011458:Prostaglandins E; D014667:Vasopressins; D000804:Angiotensin II; D005996:Nitroglycerin; D008239:Lysine